Catatan efek · kuartal yang diarsipkan
CTMX
CytomX Therapeutics, Inc. · Healthcare · Biotechnology
49Pemegang yang dilacak
-1Δ pemegang
71.30MSaham yang dipegang
$303.77MNilai yang dilaporkan
+0Posisi baru
−1Keluar
Input momentum (manajer yang sebanding):
keluasan pemegang -2.0% ·
aliran saham +23.5% ·
posisi baru bersih -2.0%
· formula
Akumulasi terkonsentrasi: saham yang meningkat di antara lebih sedikit pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q4 2025
Kepemilikan dari waktu ke waktu
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 73 | +11 | 136.41M | $511.64M | +18 | −7 |
| Q1 2026 | 64 | +15 | 111.19M | $522.57M | +20 | −5 |
| Q4 2025 | 49 | -1 | 71.30M | $303.77M | n/a | −1 |
| Q3 2025 | 14 | 0 | 41.38M | $131.99M | n/a | n/a |
| Q2 2025 | 11 | 0 | 36.17M | $82.10M | n/a | n/a |
| Q1 2025 | 8 | +1 | 8.01M | $5.09M | +1 | n/a |
| Q4 2024 | 7 | 0 | 9.00M | $9.27M | +1 | −1 |
| Q3 2024 | 6 | 0 | 8.17M | $9.64M | n/a | n/a |
| Q2 2024 | 6 | n/a | 7.95M | $9.70M | n/a | n/a |
Siapa yang memegangnya · Q4 2025
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 24.69M | +60.4% | $105.17M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 2 | The Vanguard Group ✦ (pasif) | 8.48M | -5.3% | $36.11M | 0.0% | ▼ Trim | 3 | SEC ↗ ×3 |
| 3 | Point72 Asset Management ✦ | 5.19M | +27.6% | $22.11M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 4 | State Street Global Advisors ✦ (pasif) | 5.14M | +697.1% | $21.90M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 5 | Balyasny Asset Management L.P. | 3.87M | n/a | $16.50M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Financial Engines Advisors L.L.C. | 3.83M | n/a | $16.31M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (pasif) | 3.67M | +54.0% | $15.63M | 0.0% | ▲ Add | 3 | SEC ↗ ×6 |
| 8 | Goldman Sachs Group ✦ | 2.46M | +449.6% | $10.48M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 9 | Two Sigma Investments ✦ | 1.56M | +113.9% | $6.65M | 0.0% | ▲ Add | 7 | SEC ↗ |
| 10 | Geode Capital Management ✦ (pasif) | 1.53M | -2.8% | $6.50M | 0.0% | ▼ Trim | 7 | SEC ↗ ×2 |
| 11 | Dimensional Fund Advisors Lp | 1.29M | n/a | $5.49M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 12 | Marshall Wace ✦ | 1.16M | +4.7% | $4.93M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 13 | Qube Research & Technologies Ltd | 1.06M | n/a | $4.52M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Susquehanna International Group, Llp | 981.60K | n/a | $4.18M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Bank Of America Corp /De/ | 876.30K | n/a | $3.73M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 16 | Jane Street Group, Llc | 607.22K | n/a | $2.59M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 17 | Assenagon Asset Management S.A. | 592.70K | n/a | $2.52M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | First Trust Advisors Lp | 423.17K | n/a | $1.80M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Northern Trust Corp | 415.18K | n/a | $1.77M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Morgan Stanley ✦ | 401.19K | +25.6% | $1.71M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 21 | UBS Group AG | 370.74K | n/a | $1.58M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 22 | Citadel Advisors ✦ | 342.30K | -81.0% | $1.46M | 0.0% | ▼ Trim | 7 | SEC ↗ |
| 23 | Barclays Plc | 336.52K | n/a | $1.43M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 24 | Bank of New York Mellon Corp | 328.25K | n/a | $1.40M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 25 | Raymond James Financial Inc | 316.97K | n/a | $1.35M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 26 | Millennium Management ✦ | 289.65K | -79.1% | $1.23M | 0.0% | ▼ Trim | 7 | SEC ↗ |
| 27 | Ameriprise Financial Inc | 229.60K | n/a | $988,976 | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Sei Investments Co | 124.12K | n/a | $528,768 | 0.0% | n/c | 1 | SEC ↗ |
| 29 | LPL Financial LLC | 113.44K | n/a | $483,254 | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Canada Pension Plan Investment Board | 104.20K | n/a | $443,892 | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Citigroup Inc | 96.33K | n/a | $410,349 | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Hrt Financial Lp | 71.87K | n/a | $306,000 | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Charles Schwab Investment… | 68.69K | n/a | $292,607 | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Squarepoint Ops LLC | 49.90K | n/a | $212,561 | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Tidal Investments LLC | 45.76K | n/a | $194,950 | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Hsbc Holdings Plc | 24.46K | n/a | $104,200 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 37 | JPMorgan Chase ✦ | 24.36K | -24.6% | $103,786 | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 38 | Simplex Trading, Llc | 24.05K | n/a | $102,457 | 0.0% | n/c | 1 | SEC ↗ |
| 39 | Mariner, LLC | 22.18K | n/a | $94,487 | 0.0% | n/c | 1 | SEC ↗ |
| 40 | Invesco Ltd. | 21.98K | n/a | $93,618 | 0.0% | n/c | 1 | SEC ↗ |
| 41 | Osaic Holdings, Inc. | 19.41K | n/a | $82,686 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 42 | MIRAE ASSET GLOBAL ETFS HOLDINGS… | 15.96K | n/a | $66,389 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | Victory Capital Management Inc | 14.72K | n/a | $62,716 | 0.0% | n/c | 1 | SEC ↗ |
| 44 | Bank Of Nova Scotia | 13.66K | n/a | $58,196 | 0.0% | n/c | 1 | SEC ↗ |
| 45 | Mirae Asset Global Investments Co.… | 8.23K | n/a | $35,073 | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Wells Fargo & Company/Mn | 6.61K | n/a | $28,137 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 47 | Bnp Paribas Financial Markets | 2.83K | n/a | $12,034 | 0.0% | n/c | 1 | SEC ↗ |
| 48 | Daiwa Securities Group Inc. | 564 | n/a | $2,000 | 0.0% | n/c | 1 | SEC ↗ |
| 49 | Royal Bank Of Canada | 214 | n/a | $1,000 | 0.0% | n/c | 1 | SEC ↗ |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Renaissance Technologies | $8.12M | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 178 pemegang, 193.14M saham, $906.86M dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Sering dimiliki bersama
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.
Asal-usul data: Kepemilikan dari posisi saham biasa 13F yang telah diurai (semesta yang dipantau, set pembanding untuk perubahan); baris orang dalam dari Formulir 3/4/5; kepemilikan saham signifikan dari Jadwal 13D/13G; setiap pengajuan tertaut ke dokumen aslinya di SEC EDGAR.
Periode pelaporan: Q4 2025 ·
Metodologi ·
Dapatkan ini melalui API